123 related articles for article (PubMed ID: 10370165)
1. Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines.
Yazawa Y; Takagi T; Asakura S; Suzuki K; Kano Y
J Orthop Sci; 1999; 4(3):231-7. PubMed ID: 10370165
[TBL] [Abstract][Full Text] [Related]
2. Effects of 13-hydroxy SM5887 in combination with other anticancer agents on human tumor cell lines.
Takagi T; Yazawa Y; Suzuki K; Yamauchi Y; Kano Y
Invest New Drugs; 1996; 14(4):357-63. PubMed ID: 9157070
[TBL] [Abstract][Full Text] [Related]
3. Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines.
Klaassen U; Harstrick A; Schleucher N; Vanhoefer U; Schröder J; Wilke H; Seeber S
Br J Cancer; 1996 Jul; 74(2):224-8. PubMed ID: 8688325
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide-based drug combinations: preclinical evaluation of drug interactions and translation into the clinic.
Vanhoefer U; Schleucher N; Klaassen U; Seeber S; Harstrick A
Semin Oncol; 2000 Feb; 27(1 Suppl 1):8-13. PubMed ID: 10697038
[TBL] [Abstract][Full Text] [Related]
5. Effects of mitoxantrone in combination with other anticancer agents on a human leukemia cell line.
Kano Y; Suzuki K; Akutsu M; Suda K
Leukemia; 1992 May; 6(5):440-5. PubMed ID: 1593909
[TBL] [Abstract][Full Text] [Related]
6. In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
Kano Y; Akutsu M; Tsunoda S; Suzuki K; Ichikawa A; Furukawa Y; Bai L; Kon K
Leukemia; 2000 Mar; 14(3):379-88. PubMed ID: 10720130
[TBL] [Abstract][Full Text] [Related]
7. Effects of amsacrine in combination with other anticancer agents in human acute lymphoblastic leukemia cells in culture.
Kano Y; Sakamoto S; Kasahara T; Akutsu M; Inoue Y; Miura Y
Leuk Res; 1991; 15(11):1059-66. PubMed ID: 1961009
[TBL] [Abstract][Full Text] [Related]
8. The effects of ICRF-154 in combination with other anticancer agents in vitro.
Kano Y; Narita T; Suzuki K; Akutsu M; Suda K; Sakamoto S; Miura Y
Br J Cancer; 1992 Aug; 66(2):281-6. PubMed ID: 1503899
[TBL] [Abstract][Full Text] [Related]
9. [Effects of SN-38 in combination with other anticancer agents against Dauji cells].
Akutsu M; Suzuki K; Tsunoda S; Kano Y; Miura Y
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1607-11. PubMed ID: 8060135
[TBL] [Abstract][Full Text] [Related]
10. Effects of carboplatin in combination with other anticancer agents on human leukemia cell lines.
Kano Y; Akutsu M; Suzuki K; Yoshida M
Leuk Res; 1993 Feb; 17(2):113-9. PubMed ID: 8429687
[TBL] [Abstract][Full Text] [Related]
11. [Effects of carboplatin combination with etoposide against leukemia/lymphoma cell lines].
Akutsu M; Suzuki K; Tsunoda S; Kano Y
Gan To Kagaku Ryoho; 1996 Feb; 23(3):297-302. PubMed ID: 8712822
[TBL] [Abstract][Full Text] [Related]
12. Effects of CPT-11 in combination with other anti-cancer agents in culture.
Kano Y; Suzuki K; Akutsu M; Suda K; Inoue Y; Yoshida M; Sakamoto S; Miura Y
Int J Cancer; 1992 Feb; 50(4):604-10. PubMed ID: 1537625
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.
Kano Y; Akutsu M; Tsunoda S; Izumi T; Kobayashi H; Mano H; Furukawa Y
Invest New Drugs; 2007 Feb; 25(1):31-40. PubMed ID: 16865529
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines.
Kaufmann SH; Peereboom D; Buckwalter CA; Svingen PA; Grochow LB; Donehower RC; Rowinsky EK
J Natl Cancer Inst; 1996 Jun; 88(11):734-41. PubMed ID: 8637027
[TBL] [Abstract][Full Text] [Related]
15. Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro.
Akutsu M; Furukawa Y; Tsunoda S; Izumi T; Ohmine K; Kano Y
Leukemia; 2002 Sep; 16(9):1808-17. PubMed ID: 12200697
[TBL] [Abstract][Full Text] [Related]
16. Effect of CPT-11 in combination with other anticancer agents in lung cancer cells.
Pei XH; Nakanishi Y; Takayama K; Bai F; Kawasaki M; Tsuruta N; Mizuno K; Hara N
Anticancer Drugs; 1997 Mar; 8(3):231-7. PubMed ID: 9095327
[TBL] [Abstract][Full Text] [Related]
17. The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro.
Tanaka M; Kano Y; Akutsu M; Tsunoda S; Izumi T; Yazawa Y; Miyawaki S; Mano H; Furukawa Y
Anticancer Res; 2009 Nov; 29(11):4589-96. PubMed ID: 20032408
[TBL] [Abstract][Full Text] [Related]
18. Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.
Viale M; Pastrone I; Pellecchia C; Vannozzi MO; Cafaggi S; Esposito M
Anticancer Drugs; 1998 Jun; 9(5):457-63. PubMed ID: 9660544
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of hyperthermia- and 4-hydroperoxy-ifosfamide-induced cytotoxicity in T cell leukemia.
Mauz-Körholz C; Dietzsch S; Banning U; Tröbs RB; Körholz D
Anticancer Res; 2002; 22(6C):4243-7. PubMed ID: 12553065
[TBL] [Abstract][Full Text] [Related]
20. Combined 4-hydroxy-ifosfamide and vinorelbine treatment in established and primary human breast cell cultures.
Ricotti L; Barzanti F; Tesei A; Amadori D; Gasperi-Campani A; Frassineti GL; Zoli W
Ann Oncol; 2000 May; 11(5):587-94. PubMed ID: 10907953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
